These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24156125)

  • 21. Recurrent priapism related to oxaliplatin infusion.
    Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
    J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe anaphylactic reaction to oxaliplatin.
    Alliot C; Messouak D; Beets C; Rapin JP
    Clin Oncol (R Coll Radiol); 2001; 13(3):236. PubMed ID: 11527302
    [No Abstract]   [Full Text] [Related]  

  • 23. Anaphylactic reaction to oxaliplatin: a case report.
    Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
    Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.
    Pinedo DM; Shah-Khan F; Shah PC
    J Clin Oncol; 2007 Nov; 25(33):5320-1. PubMed ID: 18024878
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
    Skelton MR; Goldberg RM; O'Neil BH
    Clin Colorectal Cancer; 2007 Jan; 6(5):386-8. PubMed ID: 17311705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
    Garziera M; Virdone S; De Mattia E; Scarabel L; Cecchin E; Polesel J; D'Andrea M; Pella N; Buonadonna A; Favaretto A; Toffoli G
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28653974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oxaliplatin and fluorouracil: bolus coadministration regimens].
    Zaniboni A; Meriggi F
    Tumori; 2001; 87(6):A24-5. PubMed ID: 11995700
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 31. FOLFIRI-bevacizumab-induced acute toxic leukoencephalopathy.
    Sertesen E; Öztaş A; Karaçin C; Yoloğlu Z
    J Oncol Pharm Pract; 2023 Sep; 29(6):1516-1519. PubMed ID: 37231633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not All That Slurs Is Stroke: A Case of Chemotherapy-Induced Leukoencephalopathy.
    Lowry LE; Fenderson JL; Baur RA
    J Oncol Pract; 2019 Jan; 15(1):55-57. PubMed ID: 30629906
    [No Abstract]   [Full Text] [Related]  

  • 33. [Analysis of a case of oxaliplatin - induced persistence sensory neuropathy].
    Matsuo K; Higuchi M; Sasaki Y; Iwatsubo S; Wada Y; Hasegawa K; Shirakawa A; Mishima K; Iwasaki K; Fujiwara M; Nishino H
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):551-4. PubMed ID: 20332703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Systemic therapy for colorectal cancer].
    Pestalozzi BC; Jäger D; Knuth A
    Chirurg; 2005 Jun; 76(6):570-2, 574. PubMed ID: 15905968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oxaliplatin].
    Bascioni R
    Suppl Tumori; 2004; 3(4):S111-2. PubMed ID: 15206232
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.
    Damodaran S; Bellavia T; Sait SN; Wang ES; Wetzler M; Khushalani NI
    Clin Colorectal Cancer; 2012 Jun; 11(2):151-4. PubMed ID: 22133502
    [No Abstract]   [Full Text] [Related]  

  • 37. Oxaliplatin-mediated autoimmune thrombocytopenia.
    Saif MW; The A; Ledbetter L
    Clin Colorectal Cancer; 2009 Jan; 8(1):61-2. PubMed ID: 19203900
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatocellular carcinoma and nodular regenerative hyperplasia after chemotherapy for metastatic colorectal carcinoma.
    Calderaro J; Azoulay D; Zafrani ES
    Hepatology; 2014 Oct; 60(4):1440-1. PubMed ID: 24604623
    [No Abstract]   [Full Text] [Related]  

  • 39. FOLFIRINOX: from the ACCORD study to 2014.
    Oikonomopoulos GM; Syrigos KN; Skoura E; Saif MW
    JOP; 2014 Mar; 15(2):103-5. PubMed ID: 24618428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy.
    Di Francia R; Siesto RS; Valente D; Spart D; Berretta M
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1211-7. PubMed ID: 23047504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.